GBLX

GB SCIENCES INC by GB Sciences, Inc. (GBLX)

About GB SCIENCES INC by GB Sciences, Inc. (GBLX)

GB Sciences, Inc. is a biopharmaceutical research and development company, which engages in creating patented, disease-targeted formulations of cannabis, and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. The company was founded on April 4, 2001, and is headquartered in Las Vegas, NV.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.01
52 Week Low
$0.00
Market cap
81,400
Dividend yield
0.00%
Volume
--
Avg. volume
23,918
P/E ratio
-.07

GB SCIENCES INC by GB Sciences, Inc. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.01
52 Week Low
$0.00
Market cap
81,400
Dividend yield
0.00%
Volume
--
Avg. volume
23,918
P/E ratio
-.07